CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
27,360,884
Share change
+2,865,865
Total reported value
$81,277,000
Put/Call ratio
0%
Price per share
$2.97
Number of holders
49
Value change
+$8,330,747
Number of buys
22
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
5.5%
6,715,462
$22,295,000 30 Sep 2014
13F
FEDERATED HERMES, INC.
13F
Company
2.5%
3,048,500
$10,121,000 30 Sep 2014
13F
FRANKLIN RESOURCES INC
13F
Company
2%
2,511,600
$8,339,000 30 Sep 2014
13F
VANGUARD GROUP INC
13F
Company
1.5%
1,875,449
$6,227,000 30 Sep 2014
13F
Visium Asset Management, LP
13F
Company
1.2%
1,500,000
$4,980,000 30 Sep 2014
13F
Broadfin Capital, LLC
13F
Company
1.1%
1,400,000
$4,648,000 30 Sep 2014
13F
MORGAN STANLEY
13F
Company
1%
1,236,179
$4,104,000 30 Sep 2014
13F
Opaleye Management Inc.
13F
Company
0.79%
975,000
$3,237,000 30 Sep 2014
13F
Catalyst Capital Advisors LLC
13F
Company
0.78%
955,000
$3,171,000 30 Sep 2014
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.56%
685,500
$2,276,000 30 Sep 2014
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.23%
282,334
$937,000 30 Sep 2014
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.2%
240,282
$798,000 30 Sep 2014
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
237,800
$789,000 30 Sep 2014
13F
TFS CAPITAL LLC
13F
Company
0.19%
229,040
$760,000 30 Sep 2014
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.16%
196,500
$652,000 30 Sep 2014
13F
BlackRock Fund Advisors
13F
Company
0.14%
175,660
$583,000 30 Sep 2014
13F
Weiss Multi-Strategy Advisers LLC
13F
Company
0.12%
150,000
$498,000 30 Sep 2014
13F
TANAKA CAPITAL MANAGEMENT INC
13F
Company
0.12%
147,993
$414,000 30 Sep 2014
13F
NORTHERN TRUST CORP
13F
Company
0.07%
89,414
$297,000 30 Sep 2014
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
82,919
$275,000 30 Sep 2014
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.07%
82,770
$275,000 30 Sep 2014
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
78,359
$260,000 30 Sep 2014
13F
COWEN INC.
13F
Company
0.09%
106,250
$255,000 30 Sep 2014
13F
Paloma Partners Management Co
13F
Company
0.06%
71,994
$239,000 30 Sep 2014
13F
Bank of New York Mellon Corp
13F
Company
0.05%
66,956
$222,000 30 Sep 2014
13F
A.R.T. Advisors, LLC
13F
Company
0.05%
62,081
$206,000 30 Sep 2014
13F
NOMURA HOLDINGS INC
13F
Company
0.04%
54,640
$181,000 30 Sep 2014
13F
STATE STREET CORP
13F
Company
0.04%
49,400
$164,000 30 Sep 2014
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.04%
46,438
$154,000 30 Sep 2014
13F
JANE STREET GROUP, LLC
13F
Company
0.04%
46,039
$153,000 30 Sep 2014
13F
CREDIT SUISSE AG/
13F
Company
0.04%
45,384
$151,000 30 Sep 2014
13F
Cowen Prime Services LLC
13F
Company
0.03%
43,025
$143,000 30 Sep 2014
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.03%
41,332
$137,000 30 Sep 2014
13F
WHALEROCK POINT PARTNERS, LLC
13F
Company
0.02%
30,400
$100,000 30 Sep 2014
13F
Financial Architects, Inc
13F
Company
0.02%
30,000
$100,000 30 Sep 2014
13F
Rotella Capital Management, Inc.
13F
Company
0.02%
22,852
$76,000 30 Sep 2014
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13F
Company
0.02%
20,998
$70,000 30 Sep 2014
13F
AGRAN LIBBIE
13F
Company
0.02%
20,000
$66,000 30 Sep 2014
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.01%
15,295
$51,000 30 Sep 2014
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.01%
12,220
$41,000 30 Sep 2014
13F
Nine Chapters Capital Management LLC
13F
Company
0.01%
10,900
$36,000 30 Sep 2014
13F
BlackRock Investment Management, LLC
13F
Company
0.01%
10,313
$34,000 30 Sep 2014
13F
CITIGROUP INC
13F
Company
0.01%
10,096
$34,000 30 Sep 2014
13F
Janney Montgomery Scott LLC
13F
Company
0.01%
10,000
$33,200 30 Sep 2014
13F
Creative Planning
13F
Company
0.01%
8,231
$27,000 30 Sep 2014
13F
Spot Trading L.L.C
13F
Company
0.01%
7,785
$26,000 30 Sep 2014
13F
FIRST NEW YORK SECURITIES LLC /NY
13F
Company
0.01%
7,500
$24,900 30 Sep 2014
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0%
4,782
$16,000 30 Sep 2014
13F
Vantage Investment Advisors, LLC
13F
Company
0%
3,000
$10,000 30 Sep 2014
13F
ROYAL BANK OF CANADA
13F
Company
0%
2,000
$7,000 30 Sep 2014
13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q4 2014

As of 31 Dec 2014, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 49 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,360,884 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, Broadfin Capital, LLC, VANGUARD GROUP INC, FEDERATED INVESTORS INC /PA/, SPHERA FUNDS MANAGEMENT LTD., Opaleye Management Inc., Catalyst Capital Advisors LLC, and Private Capital Advisors, Inc.. This page lists 49 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2014 vs Q3 2014 Across Filers

Q3 2014 holders
51
Q4 2014 holders
49
Holder diff
-2
Investor Q3 2014 Shares Q4 2014 Shares Share Diff Share Chg % Q3 2014 Value $ Q4 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .